ACE inhibitors were less commonly used in female patients (27.1% vs. 33%, p = 0.09), especially in the presence of type 2 diabetes mellitus (2.6% vs. 13.9%, p = 0.006). The gene discussed is ACE; the disease is type 2 diabetes mellitus.